405 filings
Page 7 of 21
6-K
v5f b0kd4zve1
9 Feb 21
Current report (foreign)
4:34pm
6-K
9rr65t 8yqwei
21 Jan 21
Current report (foreign)
7:49am
6-K
bkxlu9y6d5ctcwo5lnj
11 Jan 21
Current report (foreign)
4:25pm
6-K
w0uu2ba6vkl t98
6 Jan 21
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
9:57am
6-K
rrjiwkd3xwiy w6f3tbh
5 Jan 21
Selvita completes acquisition of Fidelta from Galapagos
7:00am
6-K
gyd6gyz97
15 Dec 20
Current report (foreign)
4:55pm
6-K
grx01e2q0
7 Dec 20
Current report (foreign)
10:59am
6-K
vml5m
3 Dec 20
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
4:34pm
6-K
rnnlfnlvoux7
30 Nov 20
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
5:10pm
6-K
15c xg1f3snp0vzbr
24 Nov 20
Selvita to acquire Fidelta from Galapagos
7:05am
6-K
bh6e7r8l
10 Nov 20
Current report (foreign)
6:05am
6-K
41afqu2ui20ir6r on
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
h5acogymccs
6 Nov 20
Current report (foreign)
10:06am
6-K
tcu4hm6lpc9hb4r0
3 Nov 20
Current report (foreign)
6:00am
6-K
7632w mtshps
27 Oct 20
Current report (foreign)
12:13pm
6-K
65igg xgz
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm
6-K
1x5yhy8b48i34b0
13 Oct 20
Current report (foreign)
6:15am
S-8
x8cwwdsc1qcs v846
9 Oct 20
Registration of securities for employees
4:32pm
6-K
f8lffn
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am
6-K
dwmf tklgyoyz
28 Sep 20
Current report (foreign)
6:00am